Dr. Daniel Weisdorf, MD

• Hematology

• Medical Oncology

• Internal Medicine

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Rosalind Franklin University Chicago Medical School

  Medical School, 1975

• Allogeneic Hematopoietic Cell Transplantation Compared to Chemotherapy Consolidation in older Acute Myeloid Leukemia (AML) Patients 60-75 Years in First Complete Remission (CR1): An Alliance (A151509), SWOG, ECOG-ACRIN and CIBMTR Study, 2019-05-09

• Low EGF in Myeloablative Allotransplantation: Association with Severe Acute GVHD in BMT CTN 0402, 2017-06-05

• Monosomal karyotype at the time of diagnosis or transplantation predicts outcomes of Allogeneic Hematopoietic Cell Transplantation in Myelodysplastic Syndrome, 2015-01-22

• Comparison of Outcomes of Allogeneic Transplantation for CML with Cyclophosphamide in Combination with Intravenous Busulfan, Oral Busulfan or TBI, 2014-12-17

• Early Adaptive NK Cell Expansion is Associated with Decreased Relapse After Autologous Transplant for Multiple Myeloma, 2020-12-17

• Gut microbiota response to antibiotics is personalized and depends on baseline microbiota, 2021-10-27

• Presence of donor-encoded centromeric KIR B content increases the risk of infectious mortality in recipients of myeloablative, T cell deplete, HLA-matched HCT to treat AML, 2020-03-13

• Reduced intensity allogeneic haematopoietic cell transplantation for chronic lymphocytic leukaemia: related donor and umbilical cord allografting, 2011-09-19

• Pre-transplant Consolidation is Not Beneficial for Adults with ALL Undergoing Myeloablative Allogeneic Transplantation, 2017-12-21

• Autologous is Superior to Allogeneic Hematopoietic Cell Transplantation for Acute Promyelocytic Leukemia in Second Complete Remission, 2014-03-30

• Recipient single nucleotide polymorphisms in Paneth cell antimicrobial peptide genes and acute graft-versus-host disease: Analysis of BMT CTN-0201 and -0901 samples, 2018-07-13

• Prognostic value of prior consolidation in acute myeloid leukemia patients undergoing hematopoietic cell transplantation in minimal residual disease-negative first complete remission, 2018-10-09

• Human Herpesvirus 6 Infection after Hematopoietic Cell Transplantation: Is Routine Surveillance Necessary?, 2011-04-20

• Dynamic Graft-versus-Host Disease-Free, Relapse-Free Survival: Multistate Modeling of the Morbidity and Mortality of Allotransplantation, 2019-05-22

• Hematopoietic Cell Transplant-Related Toxicities and Mortality in Frail Recipients, 2019-08-05

• Outcomes and predictors of response in steroid-refractory acute graft-versus-host disease: single-center results from a cohort of 203 patients, 2019-07-17

• Hematopoietic cell transplantation with cryopreserved grafts for severe aplastic anemia, 2020-05-08

• Pre-transplant serum citrulline predicts acute graft-versus-host disease, 2018-07-07

• History of consolidation is prognostic in acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplantation in minimal residual disease-negative first complete remission, 2017-07-29

• Follistatin and Soluble Endoglin Predict 1-year Non-Relapse Mortality after Allogeneic Hematopoietic Cell Transplant, 2019-11-10

• Sirolimus and Mycophenolate Mofetil as Calcineurin Inhibitor-Free GVHD Prophylaxis for RIC Umbilical Cord Blood Transplantation, 2016-08-09

• Novel Composite Endpoints after Allogeneic Hematopoietic Cell Transplantation, 2021-05-15

• Association between recipientTNFrs361525 and acute GVHD: Results from analysis of BMT CTN-0201 samples, 2018-03-07

• Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: Impact of tyrosine kinase inhibitor and minimal residual disease, 2013-08-30

• SEMIPARAMETRIC REGRESSION MODEL FOR RECURRENT BACTERIAL INFECTIONS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION, 2018-07-13

• Peripheral Blood versus Bone Marrow from Unrelated Donors: Bone Marrow allografts have improved Long-term Overall and Graft-versus-Host Disease, Relapse-Free Survival, 2018-10-03

• Adaptive NK cell and KIR-expressing T cell responses are induced by CMV and are associated with protection against CMV reactivation after allogeneic donor hematopoietic cell transplantation, 2015-06-06

• PROVIDING PERSONALIZED PROGNOSTIC INFORMATION FOR ADULT LEUKEMIA SURVIVORS, 2013-09-06

• Vancomycin-resistance gene cluster,vanC, in the gut microbiome of acute leukemia patients undergoing intensive chemotherapy, 2019-10-10

• A dose-finding safety and feasibility study of oral activated charcoal and its effects on the gut microbiota in healthy volunteers not receiving antibiotics, 2022-06-14

• SIMILAR OUTCOMES USING MYELOABLATIVE VERSUS REDUCED INTENSITY ALLOGENEIC TRANSPLANT PREPARATIVE REGIMENS FOR AML OR MDS, 2011-03-28

• Antibiotic practice patterns in hematopoietic cell transplantation: A survey of Blood and Marrow Transplant Clinical Trials Network centers, 2018-09-09

• Positron Emission Tomography-based Assessment of Metabolic Tumor Volume Predicts Survival after Autologous Hematopoietic Cell Transplantation for Hodgkin lymphoma, 2017-09-20

• Engraftment of double cord blood transplantation after non-myeloablative conditioning with escalated total body irradiation dosing to facilitate engraftment in immunocompetent patients, 2021-07-15

• A refined risk score for acute GVHD that predicts response to initial therapy, survival and transplant-related mortality, 2015-01-10

• Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia: No Impact of Pre-transplant Extramedullary Disease on Outcome, 2015-04-27

• Haploidentical Natural Killer Cells Induce Remissions in Non-Hodgkin Lymphoma Patients With Low Levels of Immune-suppressor Cells, 2017-12-07

• Lymphocyte phenotype during therapy for acute graft versus host disease: a brief report from BMT-CTN 0302, 2012-12-12

• High incidence of thromboembolism in patients with chronic GVHD: association with severity of GVHD and donor-recipient ABO blood group, 2021-05-18

• MYELOABLATIVE, BUT NOT REDUCED-INTENSITY, CONDITIONING OVERCOMES THE NEGATIVE EFFECT OF FLOW-CYTOMETRIC EVIDENCE OF LEUKEMIA IN AML, 2015-11-10

• Peri-transplant palifermin use and lymphocyte recovery after T-cell replete, matched related allogeneic hematopoietic cell transplantation, 2012-09-08

• Dysbiosis patterns during re-induction/salvage versus induction chemotherapy for acute leukemia, 2019-04-15

• Health Behaviors and Cancer Screening Practices in Long-term Survivors of Hematopoietic Cell Transplantation (HCT): A Report from the Bone Marrow Transplant Survivor Study (BMTSS), 2011-03-21

• The Effect of the Composition of Unrelated Donor Bone Marrow and Peripheral Blood Progenitor Cell Grafts on Transplantation Outcomes, 2009-10-12

• Survival Differences between Adolescent / Young Adults and Children with B-Precursor Acute Lymphoblastic Leukemia following Allogeneic Hematopoietic Cell Transplantation, 2012-09-06

• IL-15 Trispecific Killer Engagers (TriKEs) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function, 2016-02-04

• Effect of COVID-19 precautions on the gut microbiota and nosocomial infections GUT MICROBES, 2021-06-16

• Matching at HLA-C improved the outcomes after double umbilical cord blood transplantation for recipients of 2-4/6 HLA-matched grafts, 2016-10-29

• Risk of Venous Thromboembolism in Non-Hodgkin Lymphoma patients surviving Blood or Marrow Transplantation, 2019-08-30

• Monocyte subpopulation recovery as predictors of hematopoietic cell transplantation outcomes, 2019-01-06

• Prolonged Subcutaneous Administration of 852A, a Novel Systemic Toll-like Receptor 7 Agonist, to Activate Innate Immune Responses in Patients with Advanced Hematologic Malignancies, 2012-06-20

• Impact of chronic graft-versus-host disease on late relapse and survival on 7489 patients after myeloablative allogeneic hematopoietic cell transplantation for leukemia, 2014-10-27

• Cytochrome P450 2B6*5 Increases Relapse after Cyclophosphamide-containing Conditioning and Autologous Transplantation for Lymphoma, 2015-02-10

• Comparison of Reduced-Intensity Hematopoietic Cell Transplantation with Chemotherapy in Patients Aged 60-70 Years with Acute Myeloid Leukemia in First Remission, 2011-06-21

• Analysis of BMT CTN-0201 and -0901 samples did not reproduce the reported association between recipientREG3Ars7588571 and chronic GVHD, 2018-08-31

• Steroids vs. steroids plus additional agent in frontline treatment of acute graftversus-host disease: a systematic review and meta-analysis of randomized trials, 2016-03-10

• Circulating Angiogenic Factors Associated with Response and Survival in Patients with Acute Graft-Versus-Host Disease: Results from BMT CTN 0302 and 0802, 2015-03-07

• Circulating bacterial DNA and neutropenic fever during antileukaemia chemotherapy, 2020-07-26

• HEMORRHAGIC CYSTITIS AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION: RISK FACTORS, GRAFT SOURCE, AND SURVIVAL, 2015-07-13

• Use of Potentially Inappropriate Medications in Older Allogeneic Hematopoietic Cell Transplantation Recipients, 2020-09-10

• Impact of Allele Level HLA Mismatch on Outcomes in Recipients of Double Umbilical Cord Blood Transplantation, 2015-09-30

• Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation - A Report from CIBMTR, 2014-10-30

• Late Mortality After Bone Marrow Transplant for Chronic Myelogenous Leukemia in the Context of Prior Tyrosine Kinase Inhibitor Exposure: A Blood or Marrow Transplant Survivor Study (BMTSS) Report, 2019-08-14

• Unrelated Cord Blood Transplantation in Adult and Pediatric Acute Lymphoblastic Leukemia: Effect of Minimal Residual Disease on Relapse and Survival, 2012-03-16

• Costs of pediatric allogeneic hematopoietic-cell transplantation, 2014-06-18

• EarlyE.casseliflavusgut colonization and outcomes of allogeneic hematopoietic cell transplantation, 2019-08-08

• Infection Rates among Acute Leukemia Patients receiving Alternative Donor Hematopoietic Cell Transplantation, 2016-06-22

• Comparative Analysis of Busulfan and Cyclophosphamide versus Cyclophosphamide and Total Body Irradiation in Full Intensity Unrelated Marrow Donor Transplantation for Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia and Myelodysplasia, 2010-04-19

• Recipient T cell Exhaustion and Successful Adoptive Transfer of Haploidentical Natural Killer Cells, 2017-11-29

• No evidence for colonization of oral bacteria in the distal gut in healthy adults, 2021-10-05

• High fludarabine exposure and relationship with treatment-related mortality after nonmyeloablative hematopoietic cell transplantation, 2010-04-12

• Allogeneic hematopoietic cell transplantation in morphologic leukemia-free aplastic state, 2017-07-19

• Personalized Fludarabine Dosing To Reduce Non-Relapse Mortality In Hematopoietic Stem Cell Transplant Recipients Receiving Reduced Intensity Conditioning, 2016-03-31

• The Effect of Aging and Pre-Donation Comorbidities on the Related PBSC Donor Experience: A Report from the Related Donor Safety Study (RDSafe), 2018-11-10

• Improving Outcomes After Allogeneic Hematopoietic Cell Transplantation for Hodgkin Lymphoma in the Brentuximab Vedotin Era, 2017-01-30

• Nonparametric methods for analyzing recurrent gap time data with application to infections after hematopoietic cell transplant, 2015-11-17

• CMV Triplex vaccine to enhance adaptive NK and T-cell reconstitution after autologous hematopoietic cell transplantation, 2022-03-08

• Sibling versus Unrelated Donor Allogeneic Hematopoietic Cell Transplantation for CML: Refined HLA-matching shows more GVHD but not less relapse, 2009-08-19

• 75200 Fecal Microbiota Transplantation to Prevent Infections in Patients with Acute Myeloid Leukemia: A Double-Blind Randomized Placebo-Controlled Phase 2 Clinical Trial, 2021-03-30

• Following transplantation for AML, donorKIR Cen B02better protects against relapse thanKIR Cen B01, 2021-06-11

• Peripheral dose heterogeneity due to the thread effect in total marrow irradiation with helical tomotherapy, 2013-09-05

• Effect of post remission therapy prior to reduced intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission, 2013-11-01

• Pharmacogenetics of Steroid Responsive Acute Graft-Versus Host Disease, 2017-04-04

• Donor and Recipient Plasma Follistatin Levels are Associated with Acute Graft-versus-Host Disease in Blood and Marrow Transplant Clinical Trials Network 0402, 2017-10-23

• CIBMTR Chronic GVHD Risk Score Predicts Mortality in an Independent Validation Cohort, 2014-12-18

• OUTCOMES OF UCB TRANSPLANTATION ARE COMPARABLE IN FLT3+ AML: RESULTS OF CIBMTR, EUROCORD AND EBMT COLLABORATIVE ANALYSIS, 2017-01-25

• Association Between Genetic Variants in the Base Excision Repair Pathway and Outcomes After Hematopoietic Cell Transplants, 2010-03-11

• Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study, 2013-04-10

• Infections following Transplantation of Bone Marrow or Peripheral-Blood Stem Cells from Unrelated Donors, 2015-09-25

• A PROGNOSTIC SCORE FOR ACUTE GRAFT-VERSUS-HOST DISEASE BASED ON BIOMARKERS: A MULTICENTER STUDY, 2015-01-01

• Risk factors for acute and chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation with umbilical cord blood and matched related donors, 2015-09-11

• Venous thromboembolism in Autologous Blood or Marrow Transplant Survivors: A report from Blood or Marrow Transplant Survivor Study, 2019-07-03

• Long-term followup of a phase I/II randomized, placebo-controlled trial of palifermin to prevent graft-versus-host disease (GVHD) after related donor allogeneic hematopoietic cell transplantation (HCT), 2008-09-06

• Classifying Cytogenetics in Patients with AML in Complete Remission Undergoing Allogeneic Transplantation: A CIBMTR Study, 2011-07-31

• An exploratory analysis of mitochondrial haplotypes and allogeneic hematopoietic cell transplantation (HCT) outcomes, 2014-10-06

• Blood transfusions and pulmonary complications after hematopoietic cell transplantation, 2015-12-03

• Higher Fludarabine and Cyclophosphamide Exposures Lead to Worse Outcomes in Reduced-Intensity Conditioning Hematopoietic Cell Transplantation for Adult Hematologic Malignancy, 2021-05-24

• Longitudinal Trajectory of Frailty in Blood or Marrow Transplant Survivors: Report from the Blood or Marrow Transplant Survivor Study, 2020-11-18

• The Past, Present, and Future of NK Cells in Hematopoietic Cell Transplantation and Adoptive Transfer, 2018-03-21

• Loss of microbiota-derived protective metabolites after neutropenic fever, 2022-04-15

• Compilation of longitudinal gut microbiome, serum metabolome, and clinical data in acute myeloid leukemia, 2022-08-02

• Targeting Natural Killer cells to Acute Myeloid Leukemiain vitrowith a CD16x33 bispecific killer cell engager (BiKE) and ADAM17 inhibition, 2013-05-20

• Synopsis of Partial-Body Radiation Diagnostic Biomarkers and Medical Management of Radiation Injury Workshop, 2022-03-04

• Multi-institutional Feasibility Study of a Fast Patient Localization Method in Total Marrow Irradiation With Helical Tomotherapy: A Global Health Initiative by the International Consortium of Total Marrow Irradiation, 2014-10-30

• An alpha-defensin gene single nucleotide polymorphism modulates the gut microbiota and may alter the risk of acute graft-versus-host disease, 2020-02-21

• Absence of early HHV-6 reactivation after cord blood allograft predicts powerful graft-versus-tumor effect, 2018-05-14

• Marrow damage and hematopoietic recovery following allogeneic bone marrow transplantation for acute leukemias: effect of radiation dose and conditioning regimen, 2015-11-30

• CD56dimCD57+NKG2C+NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT, 2015-09-29

• Allotransplantation for patients age 40 years and greater with non-Hodgkin Lymphoma (NHL): encouraging progression-free survival, 2014-03-15

• Morbidity Burden in Multiple Myeloma Survivors of Autologous Transplant -a Bone Marrow Transplant Survivor Study (BMTSS), 2020-05-15

• Allogeneic Hematopoietic Cell Transplantation for Older Patients: Prognosis determined by Disease Risk Index, 2017-05-15

• ASSOCIATION BETWEEN GENETIC VARIANTS IN ADHESION MOLECULES AND OUTCOMES AFTER HEMATOPOIETIC CELL TRANSPLANTS, 2012-05-30

• Relapse of lymphoma after allogeneic hematopoietic cell transplantation: Management strategies and outcome, 2011-02-18

• Outcomes of chronic graft-versus-host disease following matched sibling donor versus umbilical cord blood transplant, 2021-01-08

• CXCR4 Expression in CD34+ Cells and Unit Predominance after Double Umbilical Cord Blood Transplantation, 2012-09-07

• Survival of AML patients relapsing after allogeneic hematopoietic cell transplantation: a CIBMTR study, 2014-11-15

• Impact of ABO-Mismatch on Risk of Graft-versus-Host Disease after Umbilical Cord Blood Transplantation, 2013-02-18

• Transplantation Related Toxicity and Mortality in Older Autologous Hematopoietic Cell Transplantation Recipients, 2017-07-19

• NCI 1st International Workshop on the Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Summary and Recommendations from the Organizing Committee, 2011-01-09

• UNRELATED DONOR ALLOGENEIC TRANSPLANTATION AFTER FAILURE OF AUTOLOGOUS TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA: A STUDY FROM THE CIBMTR, 2013-04-28

• Introduction to the Reports from the National Cancer Institute 1st International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation, 2010-03-02

• Donor killer-cell immunoglobulin-like receptorBhaplotypes, recipient HLA-C1 and HLA-C mismatch enhance the clinical benefit of unrelated transplantation for acute myelogenous leukemia, 2014-04-18

• Pediatric-inspired Therapy compared to Allografting for Philadelphia Chromosome Negative Adult ALL in First Complete Remission, 2015-12-30

• Amphiregulin in intestinal acute graft-versus-host disease: a possible diagnostic and prognostic aid, 2018-11-13

• Pretransplant Gut Colonization with Intrinsically Vancomycin-Resistant Enterococci (E. gallinarumandE. casseliflavus) and Outcomes of Allogeneic Hematopoietic Cell Transplantation, 2018-01-31

• Late mortality in blood or marrow transplant survivors with venous thromboembolism: report from the Blood or Marrow Transplant Survivor Study, 2019-03-18

• Donor killer-cell immunoglobulin-like receptor (KIR) genotype does not improve graft-versus-leukemia responses in chronic lymphocytic leukemia (CLL) after unrelated donor transplant: a CIBMTR analysis, 2018-12-27

• Human effectors of acute and chronic GVHD overexpress CD83 and predict mortality, 2023-03-14

• Prevention of graft versus host disease with Hematopoietic Cell Transplantation with Reduced Intensity Conditioning-a comparison of three prophylaxis regimens (tacrolimus/mycophenolate mofetil/cyclophosphamide, tacrolimus/methotrexate/bortezomib or tacrolimus/methotrexate/maraviroc) versus tacrolimu, 2019-04-09

• Importance of Donor Ethnicity/Race Matching in Unrelated Adult and Cord Blood Allogeneic Hematopoietic Cell Transplantation, 2013-06-12

• How closely related is graft-vs-leukemia to donor/recipient disparity?, 2010-11-01

• Allogeneic hematopoietic cell transplant outcomes in acute myeloid leukemia: Similar outcomes regardless of donor type, 2014-11-06

• Outcome of Patients With IgD and IgM Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Retrospective CIBMTR Study, 2012-05-24

• Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies, 2015-08-29

• Updated analysis of CALGB 100104 (Alliance): a randomised phase III study evaluating lenalidomide vs placebo maintenance after single autologous stem cell transplant for multiple myeloma, 2017-08-17

• A new standard in GVHD prophylaxis? An introduction to BMT CTN 1703, 2020-09-10

• DonorKIR BGenotype Improves Progression Free Survival of Non-Hodgkin lymphoma Patients Receiving Unrelated Donor Transplantation, 2016-05-21

• Hematopoietic Cell and Solid Organ Transplantation in the same patient: Long term experience at the University of Minnesota, 2020-09-17

• Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic cell transplantation program (Part I): Minimum requirements and beyond, 2019-08-20

• Haptoglobin genotype and gut barrier-related complications of allogeneic hematopoietic cell transplantation, 2019-05-08

• Phase 1 study of a bispecific ligand-directed toxin targeting CD22 and CD19 (DT2219) for refractory B-cell malignancies, 2015-03-15